Australia markets closed

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
19.03-0.17 (-0.90%)
As of 12:43PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
219,788
219,788
137,039
94,085
62,649
Cost of revenue
44,982
44,982
32,009
15,822
9,685
Gross profit
174,806
174,806
105,030
78,263
52,964
Operating expenses
Research development
53,618
53,618
44,903
29,646
13,256
Selling general and administrative
180,152
180,152
143,003
86,738
48,132
Total operating expenses
242,783
242,783
196,172
118,342
59,506
Operating income or loss
-67,977
-67,977
-91,142
-40,079
-6,542
Interest expense
11
11
17
1
2,634
Total other income/expenses net
-
-
18,287
-
-1,397
Income before tax
-57,365
-57,365
-68,904
-40,012
-10,200
Income tax expense
101
101
-1,766
-8,720
84
Income from continuing operations
-57,466
-57,466
-67,138
-31,292
-10,284
Net income
-57,466
-57,466
-67,138
-31,292
-10,284
Net income available to common shareholders
-57,466
-57,466
-67,138
-31,292
-10,284
Basic EPS
-2.84
-
-2.58
-1.24
-0.54
Diluted EPS
-2.84
-
-2.58
-1.24
-0.54
Basic average shares
26,644
-
26,054
25,137
18,929
Diluted average shares
26,644
-
26,054
25,137
18,929